Perioperative anesthetic management of the kidney-pancreas transplant recipient

Current Opinion in Anaesthesiology

Volumn 13, Issue 3, 2000, Pages 341-347

  Koehntop, Douglas E ^a,c   Beebe, David S ^a   Belani, Kumar G ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c Mayo   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; DOPAMINE; FENOLDOPAM; FENTANYL; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; ISOFLURANE; MANNITOL; MORPHINE; NICARDIPINE; NITROPRUSSIDE SODIUM; PETHIDINE; VERAPAMIL;

ALLOGRAFT; ANESTHESIA; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CARDIOVASCULAR PERFORMANCE; COMORBIDITY; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MONITORING; MORBIDITY; MORTALITY; ORGAN PERFUSION; PANCREAS TRANSPLANTATION; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; REVASCULARIZATION; SURGICAL RISK; SURGICAL TECHNIQUE; TACHYCARDIA;

EID: 0034084032     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200006000-00019     Document Type: Article

References (34)

1. 1 Koehntop DE, Beebe DS, Belani KG. Kidney transplantation. In: Anesthesia and intensive care for organ transplantation. Klinck JR, Lindop MJ (editors). London: Chapman & Hall Medical; 1998. pp. 253-280.
2. 2 Beebe DS, Liao J-C, Belani KG. Pancreas transplantation. In: Anesthesia and intensive care for organ transplantation. Klinck JR, Lindop MJ (editors). London: Chapman & Hall Medical; 1998. pp. 281-295.
3. 3 Beebe DS, Kendall DM, Gruessner RWG, Belani KG. Pancreas transplantation. In: Anesthesia and transplantation. Sharpe MD, Gelb AW (editors). Boston: Butterworth-Heinemann; 1999. pp. 217-240. This is a comprehensive, well-written review of the status of pancreas transplantation from the anesthesia, internal medicine, and surgical perspectives. It is an excellent presentation of the issues that confront anesthesiologists and of the options for managing the perioperative problems that frequently occur.
4. 4 Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730. This is a well-designed, nonrandomized, longitudinal study that provides clear, concise evidence that renal transplantation significantly reduces mortality compared with dialysis and that diabetic patients benefit even more than do nondiabetic persons.
5. 5 Hunsicker LG. A survival advantage for renal transplantation [editorial]. N Engl J Med 1999; 341:1762-1763. This is an excellent analysis of the evidence justifying renal transplantation as more a life-saving procedure than just a life-enhancing one.
6. 6 Gruessner AC, Sutherland DER. Analysis of United States and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: Clinical Transplants. Cecke JM, Terasaki PI (editors). Los Angeles: UCLA Tissue Typing Laboratory; 1998. pp. 53-71. This is an excellent overview of the outcomes in the USA of kidney-pancreas transplantation for 1994-1998. It examines the risk factors for graft loss and patient mortality. The authors are directly involved in the International Pancreas Transplant Registry, which is located at their institution in the Department of Surgery, University of Minnesota, Minneapolis, Minnesota.
7. 7 Grussner RWG, Sutherland DER, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC. Mycophenolate mofetil in pancreas transplantation. Transplantation 1998; 66:318-323. This is a good retrospective study that compared the efficacy and complications of the newer immunosuppressants with the old standards. The authors also give a good discussion on the effect these newer antirejection agents have on graft function and other recipient management issues.
8. 8 Beebe DS, Belani KG, Yoo M, Gruessner RWG, Sutherland DER. Anesthetic considerations in pancreas transplantation based on a 1-year review. Am J Anesthesiol 1995; 22:237-243.
9. 9 Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993; 44:617-621.
10. 10 Burgos LG, Ebert TJ, Asiddao C, Turner LA, Pattison CZ, Wang-Cheng R, Kampine JP. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 1989; 70:591-597.
11. 11 Page M McB, Watkins PJ. Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet 1978; 1:14-16.
12. 12 Triantafillou AN, Tsueda K, Berg J, Wieman TJ. Refractory bradycardia after reversal of muscle relaxant in a diabetic with vagal neuropathy. Anesth Analg 1986; 65:1237-1241.
13. 13 Ishihara H, Singh H, Giesecke AH. Relationship between diabetic autonomic neuropathy and gastric contents. Anesth Analg 1994; 78:943-947.
14. 14 Helfka RJ, Paganini EP. Blood pressure control in chronic dialysis patients. In: Replacement of renal function by dialysis. Mahaer JF (editor). Boston: Martinus Nijhoff; 1989. pp. 772-788.
15. 15 Benedetti E, Coady NT, Asolati M, Dunn T, Stormoen BM, Bartholomew AM, et al. A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantation. Am J Surg 1998; 175:14-17.
16. 16 Hogan K, Rusy D, Springman SR. Difficult laryngoscopy and diabetes mellitus. Anesth Analg 1988; 67:1162-1165.
17. 17 Koehntop DE, Rodman JH. Fentanyl pharmacokinetics in patients undergoing renal transplantation. Pharmacotherapy 1997; 17:746-752.
18. 18 Koehntop DE, Noormohamed SE, Fletcher CV. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation. Pharmacotherapy 1994; 14:592-599.
19. 19 Fyman PN, Reynolds JR, Moser F, Avitable M, Casthely PA, Butt K. Pharmacokinetics of sufentanil in patients undergoing renal transplantation. Can J Anaesth 1988; 35:312-315.
20. 20 Shlugman D, Dufore S, Dershwitz M, Michalowski P, Hoke J, Muir KT, et al. Respiratory effects of remifentanil in subjects with severe renal impairment compared to matched controls [abstract]. Anesthesiology 1994; 81:A1417.-
21. 21 Wiggum DC, Cork RC, Weldon ST, Gandolfi AJ, Perry DS. Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology 1985; 63:708-710.
22. 22 Ahmed JH, Grant AC, Rodger RSC, Murray GR, Elliot HL. Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipine. Br J Clin Pharmacol 1991; 32:57-62.
23. 23 Oparil S, Aronson S, Deeb M, Epstein M, Levy JH, Luther RR, et al. Fenoldopam: a new parenteral antihypertensive. Consensus roundtable on the management of perioperative hypertension and hypertensive crisis. Am J Hypertens 1999; 12:653-664. This is an outstanding overview by cardiovascular pharmacological experts in anesthesiology, surgery, and internal medicine on intravenous antihypertensive agents. The pros and cons of each drug, their indications, and their special features are clearly described and discussed.
24. 24 Singer I, Epstein M. Potential of dopamine A-1 agonists in the management of acute renal failure. Am J Kidney Dis 1998; 31:743-755.
25. 25 Shusterman NH, Elliot WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993; 95:161-168.
26. 26 Jorkasky DK, Audet P, Shusterman NH, Ilson B, Dafoe D, Hedrich D, Stote RM. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients. Am J Kidney Dis 1992; 19:567-572.
27. 27 Garwood S, Davis E, Hines RL. Fenoldopam: an effective renal preservative agent in cardiac surgery? [abstract]. Anesthesiology 1999; 91:A154.-
28. 28 Kelly SD, Friese CE, Hiros R, Feinee JR, Ascher NL. Perioperative renal protection with fenoldopam: initial experience and outcome in liver transplant recipients [abstract]. Anesthesiology 1999; 91:A239.-
29. 29 Shi Y, Zalewski A, Bravette B, Maroko AR, Maroko PR. Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine. Am Heart J 1992; 124:418-423.
30. 30 Cheung AT, Guvakov DV, Weiss SJ, Savino JS, Salgo IS, Meng QC. Nicardipine intravenous bolus dosing for acutely decreasing arterial blood pressure during general anesthesia for cardiac operations: pharmacokinetics, pharmacodynamics, and associated effects on left ventricular function. Anesth Analg 1999; 89:1116-1123. This is a very well designed study to evaluate the overall hemodynamic effect of nicardipine's specific arterial dilator action on myocardial performance and the time course of these effects after different bolus doses.
31. 31 David D, Dubois C, Loria Y. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery. J Cardiothorac Vasc Anesth 1991; 5:357-361.
32. 32 Lee TH. Reducing cardiac risk in noncardiac surgery [editorial]. N Engl J Med 1999; 341:1838-1840. This is an excellent appraisal of the extraordinary benefits and cost savings that can accrue from the widespread use of β-blockers perioperatively, for example it reduces the need for expensive coronary artery screening tests in select populations.
33. 33 Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LLM, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789-1794. This well-controlled study clearly demonstrated that β-receptor blockade is highly effective in reducing the incidence of death and myocardial ischemia during and after major noncardiac surgery in high-risk patients. The study strongly suggests that β-blockade may be one of the most cost-effective methods to reduce surgical morbidity and mortality in patients with significant coronary disease.
34. 34 Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et al. Beneficial effects from β-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91:1674-1686. This well-controlled, nonblinded study with objective hemodynamic and ischemic end-points convincingly demonstrated the hemodynamic stabilizing effects of β-blockade during emergence and in the postoperative period.